Idarubicin Hydrochloride Injection, Solution
Product Images NDC 0143-9307

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Idarubicin Hydrochloride (NDC 0143-9307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Idarubicin Hydrochloride Injection Usp Novaplus 1)

Structural Formula (Idarubicin Hydrochloride Injection Usp   Novaplus 1)
Chemical structure of Idarubicin Hydrochloride, showing the molecular arrangement including rings, hydroxyl groups, and hydrochloride component, consistent with its established chemical representation.*
FDA Label Image

Idarubicin Hydrochloride Injection 5 mg/5 mL Vial Label (Idarubicin Hydrochloride Injection Usp Novaplus 2)

Idarubicin Hydrochloride Injection 5 mg/5 mL Vial Label (Idarubicin Hydrochloride Injection Usp   Novaplus 2)
Idarubicin Hydrochloride Injection, USP 5 mg/5 mL (1 mg/mL) solution for intravenous use, packaged in a single-dose vial. The label includes dosing instructions, storage conditions, and warnings, with the product labeler identified as Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Idarubicin Hydrochloride Injection 10 mg/10 mL Vial Label (Idarubicin Hydrochloride Injection Usp Novaplus 3)

Idarubicin Hydrochloride Injection 10 mg/10 mL Vial Label (Idarubicin Hydrochloride Injection Usp   Novaplus 3)
Label for Idarubicin Hydrochloride Injection, USP, 10 mg per 10 mL (1 mg/mL) single-dose vial. The label indicates it is a sterile, isotonic solution for intravenous use only, supplied by Hikma Pharmaceuticals USA Inc. Storage instructions and caution about use under refrigeration are also shown.*
FDA Label Image

Idarubicin Hydrochloride Injection 20 mg/20 mL Vial Label (Idarubicin Hydrochloride Injection Usp Novaplus 4)

Idarubicin Hydrochloride Injection 20 mg/20 mL Vial Label (Idarubicin Hydrochloride Injection Usp   Novaplus 4)
Label for Idarubicin Hydrochloride Injection, USP, 20 mg/20 mL (1 mg/mL) solution for intravenous use. The sterile, isotonic solution is supplied in a 20 mL single-dose vial. The label includes storage instructions, warnings, and manufacturer details, indicating it is distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp Novaplus 5)

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp   Novaplus 5)
Label showing a data matrix barcode and printed information including lot number (ABCDEFGHIJ12345), expiration date (month and year format), GTIN, and serial number. This label corresponds to Idarubicin Hydrochloride 1 mg/mL injection solution by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp Novaplus 6)

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp   Novaplus 6)
Label of Idarubicin Hydrochloride injection solution, 1 mg/mL, from Hikma Pharmaceuticals USA Inc. The image shows a barcode and text fields indicating GTIN, serial number, expiration date, and lot number placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.